Company / SG&A per Share
Relay Therapeutics, Inc. SG&A per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.34
FY2025
5-year range
$0.15 / $0.62
FY2021-FY2025
Trend
-43.7%
vs FY2024
Sector context
#187 of 210
Health Care
What the data says
Relay Therapeutics, Inc.'s sg&a per share of $0.34 is lower than 89% of companies in the Health Care sector (FY2025). Improved from $0.62 to $0.34 over the past 2 years.
Based on SEC 10-K filings.
0.34 in FY2025 with a 5-year CAGR of -37.0%.
Improved from $0.62 to $0.34 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -1.8%
- 5-Year CAGR
- -37.0%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 210This company $0.34 Sector average $29.50
▼
-98.9% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 43.7% year-over-year.
- Ranks #187 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2019.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.34 | -43.7% |
| FY2024 | $0.60 | -2.9% |
| FY2023 | $0.62 | +73.5% |
| FY2022 | $0.36 | +133.3% |
| FY2021 | $0.15 | -95.5% |
| FY2020 | $3.40 | -14.5% |
| FY2019 | $3.98 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026